Patients suffering from axillary hyperhidrosis, a condition characterised by excessive sweating, may need to wait another 6 months for the…
The Company developing treatments for skin infections and diseases, Botanix Pharmaceuticals (ASX: BOT), has filed a New Drug Application (NDA)…
Stamping the letters ‘FDA’ on a Company announcement is a surefire way to flag investors’ interest. Today it was clinical…